AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 145 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $785,000 | -27.3% | 68,869 | +2.0% | 0.08% | -25.5% |
Q2 2021 | $1,080,000 | -11.4% | 67,487 | -1.1% | 0.10% | -25.0% |
Q1 2021 | $1,219,000 | +349.8% | 68,236 | +240.0% | 0.14% | +353.3% |
Q4 2020 | $271,000 | -51.7% | 20,070 | -57.9% | 0.03% | -63.0% |
Q3 2020 | $561,000 | -14.0% | 47,690 | +8.0% | 0.08% | +9.5% |
Q2 2020 | $652,000 | +41.1% | 44,154 | +29.1% | 0.07% | +13.8% |
Q1 2020 | $462,000 | – | 34,192 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |